Add BrightSurf on Google Email

More than 25% of infants not getting common childhood vaccinations, study finds

A recent study from the University of Virginia Health System found that more than a quarter of American infants in 2018 had not received all recommended childhood vaccines. Disparities were observed among African-American infants, low-income families, and those with lower education levels. The researchers warn that these gaps can lead ...

SourceUniversity of Virginia Health System·JournalHealth Equity·DateApr 29, 2021

Skipping the second shot could prolong pandemic, study finds

A Cornell-led research survey found that many Americans believe the Moderna and Pfizer-BioNTech vaccines provide weak protection against COVID-19 after a second dose. The study highlights the need for improved guidance on continued public health precautions, such as wearing masks, to combat vaccine attrition and prolong pandemic recovery.

SourceCornell University·JournalNew England Journal of Medicine·DateApr 28, 2021

Pfizer vaccine less effective against S. African variant, Ben-Gurion U. study finds

Researchers at Ben-Gurion University found the Pfizer vaccine to be moderately less effective against the South African variant, while still providing protection against the British variant and the original strain. The study was published in Cell Host and Microbe and suggests that future variants may require a modified vaccine.

The Lancet: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries

A new study estimates that vaccination against 10 major pathogens will have prevented 69 million deaths in low-income and middle-income countries between 2000 and 2030. Vaccination programs are expected to reduce mortality from these diseases by 72% for those born in 2019, with the greatest impact on children under five.

SourceThe Lancet·JournalThe Lancet·DateJan 28, 2021

Nursing researcher's experience in COVID-19 vaccine trial

A nursing researcher reflects on her experience participating in a COVID-19 vaccine trial, discussing the importance of informing patients about possible side effects. The article emphasizes the need for clinicians to prepare their patients for vaccination, ensuring informed consent and minimizing adverse reactions.

SourceJAMA Network·JournalJAMA Internal Medicine·DateDec 7, 2020

Vaccination and moral obligation

Researchers discovered that vaccinated participants were less generous to non-vaccinated individuals than to other vaccinated peers, especially among those who viewed vaccination as a moral duty. This suggests that vaccination is perceived as a societal obligation, transcending social group affiliations.

SourceProceedings of the National Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateJun 15, 2020

Adults don't need tetanus, diphtheria boosters if fully vaccinated as children, study says

A recent study published in Clinical Infectious Diseases found that adults who completed their childhood vaccination series against tetanus and diphtheria are protected for life. The researchers compared data from millions of people across North America and Europe between 2001 and 2016, concluding that booster shots are not necessary.

SourceOregon Health & Science University·JournalClinical Infectious Diseases·DateFeb 25, 2020

Detection of oral HPV DNA in teen, young adult females

Researchers detected oral HPV DNA in 6.2% of teen and young adult female participants, with detection decreasing over time since becoming sexually active. The study suggests that the HPV vaccine is less effective against certain types of oral HPV in vaccinated individuals compared to those who are fully unvaccinated.

SourceJAMA Network·JournalJAMA Network Open·DateOct 25, 2019

Study explains resurgence of pertussis

A study reveals that incomplete vaccination coverage is causing a predictable increase in pertussis cases. The vaccine's effectiveness decreases over time, allowing susceptible individuals to contract the disease. Researchers recommend targeting schoolchildren for vaccination campaigns.

SourceUniversity of Georgia·JournalScience Translational Medicine·DateApr 3, 2018

Genetic mutation could, if altered, boost FluMist vaccine effectiveness, research suggests

Researchers at Johns Hopkins Bloomberg School of Public Health have discovered a genetic mutation in the FluMist intranasal flu vaccine that has the potential to be altered to enhance its protective effect. The mutation reduces virus production, but reversing it makes the virus more active and induces a stronger immune response.